2019
DOI: 10.1016/j.amjms.2019.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…Major adverse cardiovascular events (MACE) are a commonly used endpoint in cardiovascular research (see, for example, Cardi et al and Casamira et al [32,33]). While there is no standard definition for MACE, it is a composite index made up of clinical events that reflect safety and effectiveness.…”
Section: Surrogate Endpointsmentioning
confidence: 99%
“…Major adverse cardiovascular events (MACE) are a commonly used endpoint in cardiovascular research (see, for example, Cardi et al and Casamira et al [32,33]). While there is no standard definition for MACE, it is a composite index made up of clinical events that reflect safety and effectiveness.…”
Section: Surrogate Endpointsmentioning
confidence: 99%